US OptionsDetailed Quotes

MNMD240719P18000

Watchlist

0.00
0.000.00%

15min DelayClose Jul 3 09:30 ET

0.00High0.00Low

Mind Medicine Stock Discussion

Trytosaveabit

Jun 20 06:16

Update

$Mind Medicine(MNMD.US)$ MindMed Reports Completion Of End-of-phase 2 Meeting With FDA; Says Reached Alignment On Phase 3 Development Strategy For MM120 In Generalized Anxiety Disorder
Benzinga· 2 mins ago
Rob Barrow, Chief Executive Officer of MindMed, said, "This marks a significant milestone for MindMed and for the millions of individuals affected by GAD. We are on schedule to initiate our Phase 3 clinical program for MM120 oral dissolving tablet (ODT) in GAD in the second half of this ...

Trytosaveabit

Jun 4 16:37

Update! Grrrr!

$Seelos Therapeutics(SEEL.US)$ $Cybin(CYBN.US)$ $Mind Medicine(MNMD.US)$ FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD
A panel of advisors to the U.S. FDA declined to endorse Lykos Therapeutics' application to market to psychedelic drug MDMA, also known as ecstasy, as a treatment for post-traumatic stress disorder.
The Psychopharmacologic Drugs Advisory Committee held votes on twoquestions. The first dealt was the drug's efficacy in PTSD, while the second aske...

AI Theory

May 29 13:53

$Mind Medicine(MNMD.US)$ i swear my brokerage (not moomoo) knows what stocks i buy and instantly shorts my stock

$Mind Medicine (MNMD.US)$ all work force buisness owner operators should invest into this companies products. this could not only benifit people with the disorders outlined in their descriptions but think about our work force in general I know for the agency I work for we have call ins all the time and generally speaking it's almost always the same people it isn't just my agency but national, jobs every wherewould benifit. so this company could help everyone every where! This company will ris...

Trytosaveabit

May 9 07:57

Update

$Mind Medicine(MNMD.US)$ Mind Medicine Presents New Studies At ISPOR 2024 Showing Growing Burden And Impact Of Generalized Anxiety Disorder In The U.S.
Benzinga· just
GAD Diagnosis Increases Healthcare Costs and Decreases Work Productivity and Health-Related Quality of Life-
-People with Undiagnosed GAD Incur Even Higher Total Healthcare Costs than those Diagnosed with GAD-
-Comprehensive Analyses of GAD Disease Burden in the US Conducted by MindMed; Company is Investigating New Treatments...

Jaguar8

May 8 15:02

$Mind Medicine(MNMD.US)$
NEWS
MindMed Reports First Quarter 2024 Financial Results and Business Updates
MindMed received Breakthrough Therapy Designation (BTD) from the FDA for MM120 in the treatment of GAD in adults, after positive Phase 2b results showing statistically significant activity through 12 weeks.
The Company has a strong financial position with $252.3 million in cash and cash equivalents as of March 31, 2024, sufficient to fund operations into 2026.
MindMed is on track to begin its ...

Trytosaveabit

Apr 1 16:14

Update

$Mind Medicine(MNMD.US)$ MindMed to voluntarily delist from CBOE Canada

BFSkinner

Mar 22 12:19

$Mind Medicine(MNMD.US)$ this thing is great for options today!!!

HODL LLC

Mar 12 08:52

$Mind Medicine(MNMD.US)$ buy pullback

No comment yet